Position in CADL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$81,340
+$4,500 QoQ
Shares Held
16,600
+22.1% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Taylor Financial Group, Inc. holds $99,190 across 2 Biotechnology names. CADL ranks #1 (82.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CADL |
Candel Therapeutics, Inc.
This page
|
16,600 | $81,340 | |
| 2 | MIST |
Milestone Pharmaceuticals Inc.
|
15,000 | $17,850 |
All Filings in CADL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $81,340 | 16,600 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $76,840 | 13,600 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $69,360 | 13,600 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $50,600 | 10,000 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $56,500 | 10,000 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||